Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iniparib (BSI-201) plus Gemcitabine/Carboplatin in Platinum-Sensitive Recurrent Ovarian Cancer
NCT01033123Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2009
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iniparib in ovarian cancer, sponsored by Sanofi. Started Dec 2009; status: completed.
02
Drugs
iniparib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT01033123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01033123.